Feb 10 (Reuters) - Eli Lilly LLY.N:
ADVANCELL ENTERS INTO STRATEGIC COLLABORATION WITH LILLY TO ADVANCE NOVEL TARGETED ALPHA THERAPIES FOR THE TREATMENT OF CANCER
ADVANCELL: TO EXPLORE THE POTENTIAL OF PB-212-BASED ALPHA THERAPIES WITH LILLY
Further company coverage: LLY.N